Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study

The aim of the study was to evaluate serum Endocan and Lumican levels as biomarkers for pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and to explore their associations with pediatric cardiometabolic risk factors. We conducted a cross-sectional study on 68 pediatric obese and overweight (O&O...

Descripción completa

Detalles Bibliográficos
Autores principales: Bălănescu, Anca, Codreanu, Ioana Florentina, Comanici, Valentina Daniela, Stan, Iustina Violeta, Bălănescu, Eugenia, Bălănescu, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448251/
https://www.ncbi.nlm.nih.gov/pubmed/32879879
http://dx.doi.org/10.1155/2020/2102401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448251/
https://www.ncbi.nlm.nih.gov/pubmed/32879879
http://dx.doi.org/10.1155/2020/2102401

Ejemplares similares